BIAF
BioAffinity (BIAF)
NASDAQ
$1.66-$0.03 (-1.66%)
Price as of Jun 03, 2026 7:50 PM EDT
  • $7.6M
    Market Cap
  • -80.18%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
6.2M
-34.18%
9.4M
+269.68%
2.5M
+52,627.44%
4,803
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
467
N/A
Gross Profit
6.2M
-34.18%
9.4M
+269.68%
2.5M
+58,306.34%
4,336
N/A
Sales and Marketing Expense
9.9M
-0.30%
9.9M
+46.43%
6.8M
+149.01%
2.7M
N/A
Research and Development Expense
-1.4M
-5.33%
-1.5M
-0.46%
-1.5M
+28.45%
-1.1M
N/A
Depreciation and Amortization Expense
504,836
-16.64%
605,637
+142.65%
249,592
+2,351.31%
10,182
N/A
Total Operating Expenses
16.7M
-8.63%
18.3M
+74.34%
10.5M
+161.64%
4.0M
N/A
Operating Profit
-10.6M
+18.08%
-9.0M
+12.29%
-8.0M
+98.78%
-4.0M
N/A
Interest Income
23,385
+32.79%
17,610
-85.58%
122,131
+161.48%
46,708
N/A
Interest Expense
N/A
N/A
N/A
N/A
-37,125
-98.53%
-2.5M
N/A
Interest Income and Expense and Net
23,385
+32.79%
17,610
-79.28%
85,006
+103.42%
-2.5M
N/A
Total Nonoperating Income and Expense
40,490
+292.23%
10,323
+210.47%
3,325
-99.87%
2.5M
N/A
Income before Taxes
-14.9M
+64.66%
-9.0M
+14.05%
-7.9M
-2.89%
-8.2M
N/A
Income Taxes
44,042
+278.04%
11,650
-44.51%
20,993
+753.72%
2,459
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-7.9M
-2.66%
-8.2M
N/A
Net Income from Continuing Operations Applicable to Common
-14.9M
+64.66%
-9.0M
+14.05%
-7.9M
-2.89%
-8.2M
N/A
Basic EPS and Net Income
-8.66
+1,054.67%
-0.75
-17.58%
-0.91
-49.72%
-1.81
N/A
Diluted EPS and Net Income
-8.66
+1,054.67%
-0.75
-17.58%
-0.91
-49.72%
-1.81
N/A
Basic Weighted Average Shares
1.7M
-85.81%
12.1M
+38.61%
8.7M
+94.43%
4.5M
N/A
Diluted Weighted Average Shares
1.7M
-85.81%
12.1M
+38.61%
8.7M
+94.43%
4.5M
N/A
Balance Sheet
Cash and Cash Equivalents
6.4M
+483.54%
1.1M
-60.83%
2.8M
-75.28%
11.4M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.4M
+483.54%
1.1M
-60.83%
2.8M
-75.28%
11.4M
N/A
Total Current Assets
7.6M
+180.70%
2.7M
-32.16%
4.0M
-66.79%
12.0M
N/A
Accumulated Depreciation
704,246
+31.33%
536,251
+43.72%
373,123
+38.61%
269,180
N/A
Property and Plant and Equipment and Net
265,593
-29.25%
375,385
-18.15%
458,633
+113.88%
214,438
N/A
Total Long-Term Assets
12,815
-34.87%
19,676
+22.52%
16,060
+167.67%
6,000
N/A
Total Assets
11.0M
+68.27%
6.5M
-20.77%
8.2M
-32.51%
12.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
105,161
-59.55%
260,000
N/A
N/A
N/A
11.4M
N/A
Total Current Liabilities
2.9M
-6.40%
3.1M
+38.13%
2.2M
+97.41%
1.1M
N/A
Total Long-Term Debt
41,313
+104.72%
20,180
N/A
N/A
N/A
1.0M
N/A
Total Long-Term Liabilities
244,191
-32.60%
362,278
+28.01%
283,001
-80.06%
1.4M
N/A
Total Liabilities
3.7M
-5.84%
3.9M
+16.20%
3.4M
+195.63%
1.1M
N/A
Retained Earnings
-68.6M
+27.79%
-53.6M
+20.27%
-44.6M
+21.65%
-36.7M
N/A
Total Stockholders Equity
7.3M
N/A
N/A
N/A
4.9M
-56.03%
11.0M
N/A
Total Shares Outstanding
4.5M
-71.12%
15.6M
+65.80%
9.4M
+12.09%
8.4M
N/A
Cash Flow
Cash from Operating Activities
-9.3M
+28.41%
-7.3M
+20.32%
-6.0M
+48.32%
-4.1M
N/A
Capital Expenditures
60,568
-23.41%
79,083
+245.31%
22,902
-89.59%
219,987
N/A
Cash from Investing Activities
-60,568
-23.41%
-79,083
-96.42%
-2.2M
+904.33%
-219,987
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.7M
+161.82%
5.6M
+1,731.26%
-344,984
-102.41%
14.3M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-171.58%
+79.41%
-95.64%
-69.62%
-314.84%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-77.80%
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
-99.84%
N/A
N/A
N/A
Revenue Growth
-34.18%
-112.67%
269.68%
-99.49%
52,627.44%
N/A
N/A
N/A
Current Ratio
2.60
+199.91%
0.87
-50.89%
1.77
N/A
N/A
N/A
Cash Ratio
2.22
+523.40%
0.36
-71.64%
1.26
N/A
N/A
N/A
Debt-to-Equity Ratio
0.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.01
-68.84%
0.04
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow